CureVac presented data on the shelf life of its own COVID-19 vaccine candidate CVnCoV on Thursday. According to the company,…
Read More »candidate
Stock exchange candidate CureVac reports changes on the board: Franz-Werner Haas becomes the company’s new CEO. The former Sygnis manager…
Read More »